You are here
Initiative Updates: CEO Roundtable on Cancer - China
On August 8, 2018, the CEO Roundtable on Cancer-China (上海拓新健康促进中心) organized and co-hosted an all-day Tobacco Control Workshop with the Shanghai Association on Tobacco Control (SATC) under the auspices of the Office of Shanghai Health Promotion Committee. The committee were guests of the China Financial Information Center located in the world’s second tallest building, The Shanghai Tower, in the Financial District of Lujiazui.
This was the first time that all of Shanghai’s different law enforcement agencies jointly attended an open discussion on tobacco control law enforcement. Representatives from virtually every different law enforcement agency participated to including those responsible for tobacco control at Shanghai’s airports, buses and trains as well as those who oversee and conduct cultural and athletic events in this huge metropolis. It is worth noting that only rarely do municipal government and legislative officers meet together with the media.
Senior executives of companies in Shanghai’s Lujiazui district, known as the “Wall Street of China”, pledged to create a smoke-free working environment last Wednesday. Initiated by NGO the CEO Roundtable on Cancer-China and supported by the World Health Organization, the national campaign aims to encourage as many enterprises as possible in the country to say no to smoking not only inside their offices, but also in factories, on campuses and other open spaces.
“We hope to help more employers in China to create 100 percent smoke-free workplaces, where employees are encouraged to give up smoking,” said Ray Wang, senior director of the CEO Roundtable on Cancer-China in Shanghai.
In September, CEO Roundtable on Cancer Founder, President George H. W. Bush, welcomed His Excellency, WANG Yu, MD, PhD, as Honorary Chairman of CEO Roundtable on Cancer-China. He is the recently retired Director General of the China-CDC. Professor WANG Yu has been a longtime and leading supporter of the CEO Roundtable’s work in China, and in 2016 established the China-CDC as one of its country’s first and foremost Gold Standard accredited workplaces in 2016.
In July of this year, the CEO Roundtable and China-CDC signed a Memorandum of Understanding to further promote the Gold Standard in China and collaborate on the expansion of cancer research, as well as health promotion and cancer prevention efforts in China.
More than eighty executives from more than thirty companies, more than ten hospitals and NGOs and nearly twenty government officials, including His Excellency Yupeng ZHOU, Former Vice Mayor of Shanghai, President of Shanghai Services Federation; Prof. Yu WANG, Director General, China CDC and Dr. Jinglei WU, Director General, Shanghai Municipal Health and Family Planning Commission, convened in the Four Seasons Hall, of the Xijiao State Guest Hotel on April 19, 2017 for CEO Roundtable on Cancer-China IV.
Prof. ZHAO Guoping, Chief Scientist of the Shanghai Health Academy Chinese Academy of Science (CAS) co-hosted the meeting, a highlight of which was the announcement of a Memorandum of Understanding between the CAS-MPG Partner Institute for Computational Biology and the CEO Roundtable on Cancer to align respective Big Data initiatives to facilitate overall global health research.
Dr. WANG Zefeng, Director of CAS-MPG Partner Institute for Computational Biology, said of the collaboration between the CEO Roundtable and Shanghai Institutes for Biological Science, CAS, "It’s time for us to use the data we already have to make some differences in the world. Data and science changes fast nowadays and changes our ways of thinking…I believe PDS will be the future of open access data-sharing.” Following his keynote address, CEO Roundtable on Cancer Chairman, Robert A. Bradway, participated in a signing ceremony with Prof. WANG Zefeng.
At the 20th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO), Dr. Martin J. Murphy, CEO of the CEO Roundtable on Cancer, was presented with an Outstanding Foreign Advisor Award. Dr. Murphy was recognized for his longtime and ongoing contributions to the advancement of oncology research and treatment in China and around the globe.
The CEO Roundtable on Cancer has signed its first-ever Memorandum of Understanding with a province of China. In this, the most recent of now four Memoranda executed in China, the CEO Roundtable together with the province of Hainan; agreed to a range of wellness promoting and research advancing initiatives. These include helping hospitals in the province lead by example in becoming CEO Cancer Gold Standard accredited, promoting HPV screening and vaccinations, establishing medical resource exchanges, and enabling collaborative big data research activities through the Project Data Sphere platform.